COVID-19 Information

Edit Entry | Edit CV

Anna N. A. Tosteson, ScD

Interim Director and Professor of The Dartmouth Institute
Professor of Medicine
Professor of Community and Family Medicine
James J. Carroll 1948 Professor of Oncology

Additional Titles/Positions/Affiliations:
Director, Comparative Effectiveness Research Program, The Dartmouth Institute for Health Policy and Clinical Practice
Associate Director for Population Sciences, Norris Cotton Cancer Center
Associate Director, SYNERGY, Dartmouth's Clinical and Translational Science Institute

The Dartmouth Institute
Community and Family Medicine

Biostatistics (Health Decision Sciences), Harvard University, ScD
Biostatistics, Harvard University, MS
Statistics & Biometry, Cornell University, BS

Norris Cotton Cancer Center
The Dartmouth Institute for Health Policy and Clinical Practice

Contact Information:

Dartmouth Medical School
HB 7505
One Medical Center Drive
Lebanon NH 03756

Office: WTRB 526, DHMC
Phone: 603-653-3568

Assistant: Christopher Jacobs
Asst. Phone: 603-653-0802
Asst. Email: Christopher.R.Jacobs@Dartmouth.EDU

Professional Interests:

Dr. Anna Tosteson is a decision scientist and health services researcher who studies how the diffusion of innovations in health care are changing health, costs and quality of care. Through study of diverse data sources including registries, clinical and epidemiological studies, and administrative claims data, she seeks insights into the long-term clinical and economic effects of alternative approaches to health care delivery with a focus on cancer screening, musculoskeletal disease, and women’s health.

Grant Information:

Promoting follow-up of abnormal cancer screening tests using population-based systems to support stepped care multilevel intervention. (NCI: U01CA225451 )

Risk-based breast cancer screening and surveillance in community practice. (NCI, P01CA154292)

Courses Taught:

PH 119/121; QBS 140 Decision and Cost-Effectiveness Analysis

Selected Publications:


Changes in Mammography Utilization by Women's Characteristics during the First 5 Months of the COVID-19 Pandemic.
Sprague BL, Lowry KP, Miglioretti DL, Alsheik N, Bowles EJA, Tosteson ANA, Rauscher G, Herschorn SD, Lee JM, Trentham-Dietz A, Weaver DL, Stout NK, Kerlikowske K
J Natl Cancer Inst. 2021 Mar 29; pii: djab045. doi: 10.1093/jnci/djab045. Epub 2021 Mar 29.
PMID: 33778894

Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.
Miglioretti DL, Bissell MCS, Kerlikowske K, Buist DSM, Cummings SR, Henderson LM, Onega T, O'Meara ES, Rauscher GH, Sprague BL, Tosteson ANA, Wernli KJ, Lee JM, Lee CI
JAMA Netw Open. 2021 Mar 1;4(3):e211974. doi: 10.1001/jamanetworkopen.2021.1974. Epub 2021 Mar 1.
PMID: 33764423

The Cost-Effectiveness of Reverse Total Shoulder Arthroplasty Versus Open Reduction Internal Fixation for Proximal Humerus Fractures in the Elderly.
Austin DC, Torchia MT, Tosteson ANA, Gitajn IL, Tapp SJ, Bell JE
Iowa Orthop J. 2020;40(2):20-29.
PMID: 33633504

Comparative Access to and Use of Digital Breast Tomosynthesis Screening by Women's Race/Ethnicity and Socioeconomic Status.
Lee CI, Zhu W, Onega T, Henderson LM, Kerlikowske K, Sprague BL, Rauscher GH, O'Meara ES, Tosteson ANA, Haas JS, diFlorio-Alexander R, Kaplan C, Miglioretti DL
JAMA Netw Open. 2021 Feb 1;4(2):e2037546. doi: 10.1001/jamanetworkopen.2020.37546. Epub 2021 Feb 1.
PMID: 33606032

Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women.
van Ravesteyn NT, Schechter CB, Hampton JM, Alagoz O, van den Broek JJ, Kerlikowske K, Mandelblatt JS, Miglioretti DL, Sprague BL, Stout NK, de Koning HJ, Trentham-Dietz A, Tosteson ANA, from the Breast Cancer Surveillance Consortium and the Cancer Intervention and Surveillance Modeling Network.
J Natl Cancer Inst. 2021 Jan 30; pii: djaa218. doi: 10.1093/jnci/djaa218. Epub 2021 Jan 30.
PMID: 33515225

What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strata.
Durand MA, Yen RW, O'Malley AJ, Schubbe D, Politi MC, Saunders CH, Dhage S, Rosenkranz K, Margenthaler J, Tosteson ANA, Crayton E, Jackson S, Bradley A, Walling L, Marx CM, Volk RJ, Sepucha K, Ozanne E, Percac-Lima S, Bergin E, Goodwin C, Miller C, Harris C, Barth RJ Jr, Aft R, Feldman S, Cyr AE, Angeles CV, Jiang S, Elwyn G
Cancer. 2021 Feb 1;127(3):422-436. doi: 10.1002/cncr.33248. Epub 2020 Nov 10.
PMID: 33170506

Integration of Registries with EHRs to Accelerate Generation of Real-World Evidence for Clinical Practice and Learning Health Systems Research: Recommendations from a Workshop on Registry Best Practices.
Franklin PD, Lurie J, Tosteson TD, Tosteson ANA, Task Force on Musculoskeletal Registries.
J Bone Joint Surg Am. 2020 Oct 7;102(19):e110. doi: 10.2106/JBJS.19.01464.
PMID: 33027129

The Development of a Crosswalk for Functional Measures in Postacute Medicare Claims.
McDonough CM, Carmichael D, Marino ME, Ni P, Tosteson ANA, Bynum JPW
Phys Ther. 2020 Sep 28;100(10):1862-1871. doi: 10.1093/ptj/pzaa117.
PMID: 32949237

Screening Performance of Digital Breast Tomosynthesis vs Digital Mammography in Community Practice by Patient Age, Screening Round, and Breast Density.
Lowry KP, Coley RY, Miglioretti DL, Kerlikowske K, Henderson LM, Onega T, Sprague BL, Lee JM, Herschorn S, Tosteson ANA, Rauscher G, Lee CI
JAMA Netw Open. 2020 Jul 1;3(7):e2011792. doi: 10.1001/jamanetworkopen.2020.11792. Epub 2020 Jul 1.
PMID: 32721031

Assessment of Radiologist Performance in Breast Cancer Screening Using Digital Breast Tomosynthesis vs Digital Mammography.
Sprague BL, Coley RY, Kerlikowske K, Rauscher GH, Henderson LM, Onega T, Lee CI, Herschorn SD, Tosteson ANA, Miglioretti DL
JAMA Netw Open. 2020 Mar 2;3(3):e201759. doi: 10.1001/jamanetworkopen.2020.1759. Epub 2020 Mar 2.
PMID: 32227180

View more publications on PubMed